Back to Search
Start Over
Gram-Negative Bacteria Salmonella typhimurium Boost Leukotriene Synthesis Induced by Chemoattractant fMLP to Stimulate Neutrophil Swarming.
- Source :
-
Frontiers in pharmacology [Front Pharmacol] 2022 Jan 04; Vol. 12, pp. 814113. Date of Electronic Publication: 2022 Jan 04 (Print Publication: 2021). - Publication Year :
- 2022
-
Abstract
- Leukotriene synthesis in neutrophils is critical for host survival during infection. In particular, leukotriene B <subscript>4</subscript> (LTB <subscript>4</subscript> ) is a powerful neutrophil chemoattractant that plays a crucial role in neutrophil swarming. In this work, we demonstrated that preincubation of human neutrophils with Salmonella typhimurium strongly stimulated LTB <subscript>4</subscript> production induced by the bacterial chemoattractant, peptide N-formyl-L-methionyl-L-leucyl-l-phenylalanine (fMLP), while the reverse sequence of additions was ineffective. Preincubation with bacterial lipopolysaccharide or yeast polysaccharide zymosan particles gives weaker effect on fMLP-induced LTB <subscript>4</subscript> production. Activation of 5-lipoxygenase (5-LOX), a key enzyme in leukotrienes biosynthesis, depends on rise of cytosolic concentration of Ca <superscript>2+</superscript> and on translocation of the enzyme to the nuclear membrane. Both processes were stimulated by S. typhimurium . With an increase in the bacteria:neutrophil ratio, the transformation of LTB <subscript>4</subscript> to ω-OH-LTB <subscript>4</subscript> was suppressed, which further supported increased concentration of LTB <subscript>4</subscript> . These data indicate that in neutrophils gathered around bacterial clusters, LTB <subscript>4</subscript> production is stimulated and at the same time its transformation is suppressed, which promotes neutrophil swarming and elimination of pathogens simultaneously.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Golenkina, Galkina, Pletjushkina, Chernyak, Gaponova, Romanova and Sud’ina.)
Details
- Language :
- English
- ISSN :
- 1663-9812
- Volume :
- 12
- Database :
- MEDLINE
- Journal :
- Frontiers in pharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 35058789
- Full Text :
- https://doi.org/10.3389/fphar.2021.814113